Cryopreservation of hematopoietic stem cells: Emerging science, technology and issues

Transfusion Medicine and Hemotherapy

Volumn 34, Issue 4, 2007, Pages 268-275

  Fleming, Katie K ^a   Hubel, Allison ^a  

^a University of Minnesota   (United States)

Author keywords

Cryopreservation; Hematopoietic stem cells; Microfluidics; Storage

Indexed keywords

BLOOD STORAGE; CELL LOSS; CELL PROLIFERATION; CELL TRANSPORT; CRYOPRESERVATION; FREEZING; HEMATOPOIETIC STEM CELL; MICROFLUIDICS; REVIEW;

EID: 34547820863     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104213     Document Type: Review

References (94)

1. Areman EM, Sacher RA, Deeg HJ: Processing and storage of human bone marrow: a survey of current practices in North America. Bone Marrow Transplant 1990;6:203-209.
2. Areman EM, Sacher RA, Deeg HJ: Cryopreservation and storage of human bone marrow: a survey of current practices. Prog Clin Biol Res 1990;333:523-529.
3. Barnes D, Loutit J: The radiation recovery factor: preservation by the Polge-Smith-Parkes technique. J Natl Cancer Inst 1955;15:901-905.
4. Appelbaum FR, Herzig GP, Graw RG, Bull MI, Bowles C, Gorin NC, Deisseroth AB: Study of cell dose and storage time on engraftment of cryopreserved autologous bone marrow in a canine model. Transplantation 1978;26:245-248.
5. Rowley SD: Hematopoietic stem cell processing and cryopreservation. J Clin Apheresis 1992;7:132-134.
6. Rowley SD, Bensinger WI, Gooley TA, Buckner CD: Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994;83:2731-2736.
7. Fraser JK, Cairo MS, Wagner EL, McCurdy PR, Baxter-Lowe LA, Carter SL, Kernan NA, Lill MC, Slone V, Wagner JE, Wallas CH, Kurtzberg J: Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother 1998;7:521-561.
8. M-Reboredo N, Diaz A, Castro A, Villaescusa RG: Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant 2000;26:1263-1270.
9. Shlebak AA, Marley SB, Roberts IA, Davidson RJ, Goldman JM, Gordon MY: Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation. Bone Marrow Transplant 1999;23:131-136.
10. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE: Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-10122.
11. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J: Hematopoietic engraftment and survival in adult recipients of umbilical- cord blood from unrelated donors. N Engl J Med 2001;344:1815-1822.
12. Campos L, Roubi N, Guyotat D: Definition of optimal conditions for collection and cryopreservation of umbilical cord hematopoietic cells. Cryobiology 1995;32:511-515.
13. Hubel A, Carlquist D, Clay M, McCullough J: Short term liquid storage of umbilical cord blood. Transfusion 2003;43:626-632.
14. Hubel A, Carlquist D, Clay M, McCullough J: Cryopreservation of cord blood after liquid storage. Cytotherapy 2003;5:370-376.
15. Hubel A, Carlquist D, Clay M, McCullough J: Liquid storage, shipment, and cryopreservation of cord blood. Transfusion 2004;44:518-525.
16. Chrysler G, McKenna D, Schierman T, Kadidlo D, Askari S, Miller J, Clay M, McCullough J: Umbilical cord blood banking; in Broxmeyer HE (ed): Cellular Characteristics of Cord Blood and Cord Blood Transplantation. Bethesda, AABB Press, 2004, pp 219-257.
17. Sputtek A: Cryopreservation of red blood cells, platelets, lymphocytes, and stem cells. in Fuller B, Grout B (eds): Clinical Applications of Cryobiology. Boca Raton, CRC Press, 1991, pp 95-147.
18. Sputtek A: Kryokonservierung von Blutzellen und hamatoppoetischen Stammzellen; in Müller-Eckhart C, Kiefel V (Hrsg): Transfusionsmedizin. Berlin, Springer, 2004.
19. Sputtek A, Gutensohn K, Hummel K, Loliger C, Kühnl P: Zur Kryokonsevierung von Blutstammzellen. J Lab Med 1996;20:70-77.
20. Sputtek A, Sputtek R: Cryopreservation in transfusion medicine and hematology; in Fuller BJ, Lane N, Benson E (eds): Life in the Frozen State. Boca Raton, CRC Press, 2004, pp 483-504.
21. Fleming KK, Hubel A: Cryopreservation of hemato-poietic and non-hematopoietic stem cells. Transfus Apher Sci 2006;34:309-315.
22. Gee AP: Challenges in autologous graft manipulation; in Dickie K, Keating A (eds): Autologous Blood and Marrow Transplantation. Charlottesville, CJP, 2001, vol X, pp 19-29.
23. Hubel A: Cellular preservation - gene therapy, cellular metabolic engineering; in Baust JG (ed): Advances in Biopreservation. Boca Raton, CRC Press, 2006, pp 143-156.
24. Zaheer HA, Gibson FM, Bagnara M, Gordon-Smith EC, Rutherford TR: Differential sensitivity to cryopreservation of clonogenic progenitor cells and stromal precursors from leukemic and normal bone marrow. Stem Cells 1994;12:180-186.
25. Xu Y, Kashiwakura I, Takahashi TA: High sensitivity of megakaryocytic progenitor cells contained in placental/umbilical cord blood to the stresses during cryopreservation. Bone Marrow Transplant 2004;34:537-543.
26. de Boer F, Drager AM, Pinedo HM, Kessler FL, Monnee-van Muijen M, Weijers G, Westra G, van der Wall E, Netelenbos T, Oberink JW, Huijgens PC, Schuurhuis GJ: Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts. J Hematother Stem Cell Res 2002;11:951-963.
27. de Boer F, Drager AM, Pinedo HM, Kessler FL, van der Wall E, Jonkhoff AR, van der Lelie J, Huijgens PC, Ossenkoppele GJ, Schuurhuis GJ: Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002;29:249-255.
28. Greco NJ, Seetharaman S, Kurtz J, Lee WR, Moroff G: Evaluation of the reactivity of apoptosis markers before and after cryopreservation in cord blood CD34(+) cells. Stem Cells Dev 2006;15:124-135.
29. Stroh C, Cassens U, Samraj AK, Sibrowski W, Schulze-Osthoff K, Los M: The role of caspases in cryoinjury: caspase inhibition strongly improves the recovery of cryopreserved hematopoietic and other cells. Faseb J 2002;16:1651-1653.
30. Sarkar S, Kalia V, Montelaro RC: Caspase-mediated apoptosis and cell death of rhesus macaque CD4+ T-cells due to cryopreservation of peripheral blood mononuclear cells can be rescued by cytokine treatment after thawing. Cryobiology 2003;47:44-58.
31. Stroncek DF, Hubel A, Shankar RA, Burger SR, Pan D, McCullough J, Whitley CB: Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome. Transfusion 1999;39:343-350.
32. Aksan A, Toner M: Roles of thermodynamic state and molecular mobility in biopreservation; in Bronzino JD (ed): Tissue Engineering and Artificial Organs. Boca Raton, Taylor and Francis, 2006, pp 1-20.
33. Limaye LS, Kale VP: Cryopreservation of human hematopoietic cells with membrane stabilizers and bioantioxidants as additives in the conventional freezing medium. J Hematother Stem Cell Res 2001;10:709-718.
34. Sasnoor LM, Kale VP, Limaye LS: Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells. J Hematother Stem Cell Res 2003;12:553-564.
35. Sasnoor LM, Kale VP, Limaye LS: A combination of catalase and trehalose as additives to conventional freezing medium results in improved cryoprotection of human hematopoietic cells with reference to in vitro migration and adhesion properties. Transfusion 2005;45:622-633.
36. Scheinkönig C, Kappicht S, Kolb HJ, Schleuning M: Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells. Bone Marrow Transplant 2004;34:531-536.
37. Zhang XB, Li K, Yau KH, Tsang KS, Fok TF, Li CK, Lee SM, Yuen PM: Trehalose ameliorates the cryopreservation of cord blood in a preclinical system and increases the recovery of CFUs, long-term culture-initiating cells, and nonobese diabetic-SCID repopulating cells. Transfusion 2003;43:265-272.
38. Buchanan SS, Gross SA, Acker JP, Toner M, Carpenter JF, Pyatt DW: Cryopreservation of stem cells using trehalose: evaluation of the method using a human hematopoietic cell line. Stem Cells Dev 2004;13:295-305.
39. Erdag G, Eroglu A, Morgan J, Toner M: Cryopreservation of fetal skin is improved by extracellular trehalose. Cryobiology 2002;44:218-228.
40. Eroglu A, Lawitts JA, Toner M, Toth TL: Quantitative microinjection of trehalose into mouse oocytes and zygotes, and its effect on development. Cryobiology 2003;46:121-134.
41. Wright DL, Eroglu A, Toner M, Toth TL: Use of sugars in cryopreserving human oocytes. Reprod Biomed Online 2004;9:179-186.
42. Beattie GM, Crowe JH, Lopez AD, Cirulli V, Ricordi C, Hayek A: Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes 1997;46:519-523.
43. Wolkers W, Walker N, Tablin F, Crowe JH: Human platelets loaded with trehalose survive freeze-drying. Cryobiology 2000;42:79-87.
44. Wolkers WF, Tablin F, Crowe JH: From anhydrobiosis to freeze-drying of eukaryotic cells. Comp Biochem Physiol A Mol Integr Physiol 2002;131:535-543.
45. Satipathy G, Torok Z, Bali R, Dwyre D, Little E, Walker N, Tablin F, Crowe JH, Tsvetkova N: Loading red blood cells with trehalose: a step towards biostabilization. Cyobiology 2004;49:123-136.
46. Acker JP: The use of intracellular protectants in cell biopreservation. in Baust JG, Baust JM (eds): Advances in Biopreservation. Boca Raton, CRC Press, 2006, pp 299-320.
47. Fahy GM, Lilley TH, Linsdell H, Douglas MS, Meryman HT: Cryoprotectant toxicity and cryoprotectant toxicity reduction: in search of molecular mechanisms. Cryobiology 1990;27:247-268.
48. Rowley SD, Anderson GL: Effect of DMSO exposure without cryopreservation on hematopoietic progenitor cells. Bone Marrow Transplant 1993;11:389-393.
49. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, Klersy C, Martinelli G, Maiocchi M, Pagnucco G, Varettoni M, Perotti C, Bernasconi C: Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999;23:533-537.
50. Davis J, Rowley SD, Santos GW: Toxicity of autologous bone marrow graft infusion. Prog Clin Biol Res 1990;333:531-540.
51. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J: Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-526.
52. Berenson RJ, Shpall EJ, Auditore-Hargreaves K, Heimfeld S, Jacobs C, Krieger MS: Transplantation of CD34+ hematopoietic progenitor cells. Cancer Invest 1996;14:589-596.
53. Zenhausern R, Tobler A, Leoncini L, Hess OM, Ferrari P: Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 2000;79:523-526.
54. Martino M, Morabito F, Messina G, Irrera G, Pucci G, Iacopino P: Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 1996;81:59-61.
55. Hoyt R, Szer J, Grigg A: Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000;25:1285-1287.
56. Smith DM, Weisenburger DD, Bierman P, Kessinger A, Vaughan WP, Armitage JO: Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 1987;2:195-201.
57. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P: Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 2000;25:1299-1301.
58. Garaventa A, Porta F, Rondelli R, Dini G, Meloni G, Bonetti F, Uderzo C, De Manzini A, Miniero R, Brutti F, et al: Early deaths in children after BMT. Bone Marrow Transplantation Group of the Italian Association for Pediatric Hematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant 1992;10:419-423.
59. Okamoto Y, Takaue Y, Saito S, Shimizu T, Suzue T, Abe T, Sato J, Hirao A, Watanabe T, Kawano Y, et al: Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993;33:578-581.
60. Thome S, Craze J, Mitchell C: Dimethylsulphoxide-induced serum hyperosmolality after cryopreserved stem-cell graft. Lancet 1994;344:1431-1432.
61. Antonenas V, Bradstock K, Shaw P: Effect of washing proceedures on unrelated cord blood units for transplantation in children and adults. Cytotherapy 2002;4:16.
62. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S: The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004;10:135-141.
63. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G: Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998;18:4705-4708.
64. Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J: Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion 2005;45:1909-1916.
65. Perotti CG, Fante CD, Viarengo G, Papa P, Rocchi L, Bergamaschi P, Bellotti L, Marchesi A, Salvaneschi L: A new automated cell washer device for thawed cord blood units. Transfusion 2004;44:900-906.
66. Valeri CR: The in vivo survival, mode of removal of the non-viable cells, and the total amount of supernatant hemoglobin in deglycerolized, resuspended erythrocytes. I. The effect of the period of storage in ACD at 4C prior to glycerolization. II. The effect of washing deglycerolized, resuspended erythrocytes after a period of storage at 4C. Transfusion 1965;5:273-285.
67. Valeri CR, Pivacek LE, Cassidy GP, Ragno G: Posttransfusion survival (24-hour) and hemolysis of previously frozen, deglycerolized RBCs after storage at 4 degrees C for up to 14 days in sodium chloride alone or sodium chloride supplemented with additive solutions. Transfusion 2000;40:1337-1340.
68. Valeri CR, Pivacek LE, Cassidy GP, Ragno G: 24-hour 51Cr post-transfusion survival, 51Cr life span and haemolysis of red blood cells stored at 4 degrees C for 56 days in AS-3. Vox Sang 2001;80:48-50.
69. Arnaud F: Use of hollow fiber membrane filtration for the removal of DMSO from platelet concentrates. Platelets 2003;14:131-137.
70. Fleming KK, Longmire EA, Hubel A: Numerical characterization of diffusion-based extraction in cell-laden flow through a microfluidic channel. J Biomech Engr 2007;(in press).
71. Mata C, Longmire EA, Fleming KK, Hubel A: Experimental Study of Diffusion-Based Extraction from a Cell Suspension; in BMES Annual Meeting. Chicago, IL, BMES, 2006.
72. Stiff PJ, Koester AR, Weidner MK, Dvorak K, Fisher RI: Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987;70:974-978.
73. Stiff PJ, Murgo AJ, Zaroulis CG, DeRisi MF, Clarkson BD: Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch. Cryobiology 1983;20:17-24.
74. Katayama Y, Yano T, Bessho A, Deguchi S, Sunami K, Mahmut N, Shinagawa K, Omoto E, Makino S, Miyamoto T, Mizuno S, Fukuda T, Eto T, Fujisaki T, Ohno Y, Inaba S, Niho Y, Harada M: The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 1997;19:283-287.
75. Halle P, Tournilhac O, Knopinska-Posluzny W, Kanold J, Gembara P, Boiret N, Prapatel C, Berger M, Travade M, Angeilski S, Bonhomme J, Demeocq F: Uncontrolled-rate freezing and storage at -80 decrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001;41:467-473.
76. Galmes A, Besalduch J, Bargay J, Matamoros N, Duran MA, Morey M, Alvarez F, Mascaro M: Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at -80 degrees C without rate-controlled freezing. Transfusion 1996;36:794-797.
77. Galmes A, Besalduch J, Bargay J, Matamoros N, Morey M, Novo A, Sampol A: A simplified method for cryopreservation of hematopoietic stem cells with -80 degrees C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant. Leuk Lymphoma 1995;17:181-184.
78. Galmes A, Besalduch J, Bargay J, Novo A, Morey M, Guerra JM, Duran MA: Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion 1999;39:70-73.
79. Almici C, Ferremi P, Lanfranchi A, Ferrari E, Verardi R, Marini M, Rossi G: Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors. Haematologica 2003;88:1390-1395.
80. Sputtek A, Nowicki B, Rowe AW, Kühnl P: Long-term cryopreservation of human peripheral blood progenitor cells (PBPC): influence of storage temperature (-80 °C vs. ≤170 °C) on cell recovery, membrane integrity, and clonogenicity. Cryobiology 2004;49:314.
81. Sputtek A, Rowe AW, Kühnl P: Long-term storage of peripheral blood progenitor cells at -80oC leads to a pronounced decrease of the clonogenic potential compared to £170°C storage in the vapor phase over liquid nitrogen. Cryobiology 2005;51:355.
82. Fowke KR, Behnke J, Hanson C, Shea K, Cosentino LM: Apoptosis: a method for evaluating the cryopreservation of whole blood and peripheral blood mononuclear cells. J Immunol Methods 2000;244:139-144.
83. Cocks FH, Brower W: Phase diagram relationship in cryobiology. Cryobiology 1974;11:340-358.
84. Pegg DE: Equations for obtaining melting points and eutectic temperatures for three ternary system dimethyl sulphoxide/sodium chloride/water. CryoLetters 1986;7.
85. Tappel A: Effects of low temperature and freezing on enzymes and enzyme systems; in Meryman HT (ed): Cryobiology. New York, Academic Press, 1966, pp 163-177.
86. Sputtek A, Benndorf C, Rowe AW, Kühnl P: Post-thaw storage of frozen peripheral blood stem cells decreases the hematopoietic potential. Cryobiology 2002;45:248-249.
87. Burger SR, Kadidlo D, McCullough J: Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony stimulating factor. Tranfusion 1999;39:451-456.
88. Pegg DE: Viability assays for preserved cells, tissues, and organs. Cryobiology 1989;26:212-231.
89. Mazur P: Principles of cryobiology; in Fuller BJ, Lane N, Benson E (eds): Life in the Frozen State. Boca Raton, CRC Press, 2004, pp 3-66.
90. Taylor MJ: Biology of cell survival in the cold: the basis for biopreservation of tissues and organs; in Baust JG, Baust JM (eds): Advances in Biopreservation. Boca Raton, CRC Press, 2006, pp 15-62.
91. Keeney M, Barnett D, Gratama JW: Impact of standardization on clinical cell analysis by flow cytometry. J Biol Regul Homeost Agents 2004;18:305-312.
92. Keeney M, Gratama JW, Sutherland DR: Critical role of flow cytometry in evaluating peripheral blood hematopoietic stem cell grafts. Cytometry A 2004;58:72-75.
93. Rivadeneyra-Espinoza L, Perez-Romano B, Gonzalez-Flores A, Guzman-Garcia MO, Carvajal-Armora F, Ruiz-Arguelles A: Instrument- and protocol-dependent variation in the enumeration of CD34+ cells by flow cytometry. Transfusion 2006;46:530-536.
94. Itoh T, Minegishi M, Fushimi J, Takahashi H, Kudo Y, Suzuki A, Narita A, Sato Y, Akagi K, Wada Y, Saito A, Kikuchi M, Okamura K, Kaku M, Tsuchiya S: A simple controlled-rate freezing method without a rate-controlled programmed freezer provides optimal conditions for both large-scale and small-scale cryopreservation of umbilical cord blood cells. Transfusion 2003;43:1303-1308.